Bullish option flow detected in Crispr Therapeutics with 11,148 calls trading, 4x expected, and implied vol increasing almost 8 points to 82.87%. 12/1 weekly 75 calls and 11/24 weekly 80 calls are the most active options, with total volume in those strikes near 1,900 contracts. The Put/Call Ratio is 0.21. Earnings are expected on February 20th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CRSP:
- Crispr Therapeutics (NASDAQ:CRSP) Notches Up on World-First Therapy
- Vertex Pharmaceuticals, Crispr Therapeutics get MHRA authorization for Casgevy
- Crispr Therapeutics call volume above normal and directionally bullish
- Crispr Therapeutics price target lowered to $50 from $55 at RBC Capital
- Crispr Therapeutics price target lowered to $85 from $88 at Needham
